| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/19/1996 | CA2224170A1 Delivery of drugs to the lower gi tract |
| 12/19/1996 | CA2224162A1 Purified galactomannan as an improved pharmaceutical excipient |
| 12/19/1996 | CA2224102A1 Bacterial inhibition with an oligosaccharide compound |
| 12/19/1996 | CA2224064A1 Methods and system for processing dispersible fine powders |
| 12/19/1996 | CA2224006A1 Delivery of oxygen-supersaturated physiologic solutions |
| 12/19/1996 | CA2223934A1 Separation of active complexes |
| 12/19/1996 | CA2223928A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | CA2223925A1 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions |
| 12/19/1996 | CA2223923A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | CA2223921A1 Stabilization of polynucleotide complexes |
| 12/19/1996 | CA2223834A1 Composition for sustained release of non-aggregated erythropoietin |
| 12/19/1996 | CA2223832A1 Method for the treatment of corticosteroid induced osteopenia |
| 12/19/1996 | CA2223808A1 Process for making liposome preparation |
| 12/19/1996 | CA2223788A1 Intracellular delivery of macromolecules |
| 12/19/1996 | CA2223637A1 A method of transfection of cells using liposomally encapsulated nucleic acids |
| 12/19/1996 | CA2223605A1 Stable formulations of mhc-peptide complexes |
| 12/19/1996 | CA2223590A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| 12/19/1996 | CA2223583A1 Device for releasing aggregation-stabilized, biologically active agent |
| 12/19/1996 | CA2223446A1 Thrombopoietin compositions |
| 12/19/1996 | CA2223436A1 Composition for sustained release of human growth hormone |
| 12/19/1996 | CA2223246A1 Cell line producing analgesic compounds for treating pain |
| 12/19/1996 | CA2223179A1 Phosphonic acid-based cationic lipids |
| 12/19/1996 | CA2223088A1 Novel carbamate-based cationic lipids |
| 12/19/1996 | CA2222930A1 Treatment of a trabecular meshwork whose cells are subject to inhibition of cell division with non-steroidal anti-inflammatory drugs |
| 12/19/1996 | CA2222929A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork |
| 12/19/1996 | CA2222776A1 Biological agent compositions |
| 12/19/1996 | CA2222595A1 Therapeutic microdevices and methods of making and using same |
| 12/19/1996 | CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 12/19/1996 | CA2222538A1 Apparatus and method for delivering a biologically active compound into a biological environment |
| 12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
| 12/19/1996 | CA2222224A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 12/19/1996 | CA2222154A1 Acyclovir derivatives for topical use |
| 12/19/1996 | CA2222120A1 Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill material |
| 12/19/1996 | CA2222081A1 Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents |
| 12/19/1996 | CA2222063A1 Reverse fluorocarbon emulsion compositions for drug delivery |
| 12/19/1996 | CA2221965A1 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 12/19/1996 | CA2221323A1 Oral delivery of gene constructs |
| 12/19/1996 | CA2221310A1 Improved liposomal formulation |
| 12/19/1996 | CA2221263A1 Novel formulations for transdermal delivery of pergolide |
| 12/19/1996 | CA2219035A1 Fragrances and flavorants |
| 12/19/1996 | CA2197244A1 Wound healing formulations containing human plasma fibronectin |
| 12/18/1996 | EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them |
| 12/18/1996 | EP0748633A2 Adhesive tissue and its use as haemostyptic |
| 12/18/1996 | EP0748630A1 Urinastatin-containing suppository |
| 12/18/1996 | EP0748629A1 Percutaneously absorbable plaster comprising acid-addition salt of morphine |
| 12/18/1996 | EP0748628A2 Oral formulations of S(+)-Etodolac |
| 12/18/1996 | EP0748626A1 Patch containing isosorbide dinitrate and prepared by using adhesive mixture |
| 12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 12/18/1996 | EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
| 12/18/1996 | EP0748377A1 IMPROVED DNase LIQUID SOLUTIONS |
| 12/18/1996 | EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
| 12/18/1996 | EP0748342A1 Block and graft copolymers and methods relating thereto |
| 12/18/1996 | EP0748332A1 New cholesterol derivative for liposomal gene transfer |
| 12/18/1996 | EP0748228A1 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 12/18/1996 | EP0748227A1 Gas-containing microcapsules useful as contrast agents for diagnostic imaging |
| 12/18/1996 | EP0748225A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
| 12/18/1996 | EP0748222A1 Antitussive composition containing an antitussive and benzydamine |
| 12/18/1996 | EP0748220A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| 12/18/1996 | EP0748218A1 Plaster-shaped transdermal system with a tamoxifen derivative |
| 12/18/1996 | EP0748216A1 Systemic drug delivery system through application on nails |
| 12/18/1996 | EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 12/18/1996 | EP0748214A1 Liposomes and use thereof especially to obtain immunomodulating compositions |
| 12/18/1996 | EP0748213A1 Methods and compositions for pulmonary delivery of insulin |
| 12/18/1996 | EP0748212A1 Oral vehicle compositions |
| 12/18/1996 | EP0748211A1 Anthelmintic preparation |
| 12/18/1996 | EP0748208A1 Cosmetic and/or pharmaceutical preparations |
| 12/18/1996 | EP0748203A1 LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES |
| 12/18/1996 | EP0748191A1 Methods and formulations for use in treating oophorectomized women |
| 12/18/1996 | EP0748190A1 Methods and formulations for use in treating benign gynecological disorders |
| 12/18/1996 | EP0695171B1 Lyospheres comprising gonadotropin |
| 12/18/1996 | EP0690855B1 Benzopyranes as potassium channel openers |
| 12/18/1996 | EP0666736B1 Stabilization of fluorocarbon emulsions |
| 12/18/1996 | EP0661958B1 Transfer process for making transdermal therapeutic systems |
| 12/18/1996 | EP0621774B1 Improved process for preparing micronized polypeptide drugs |
| 12/18/1996 | EP0577622B1 Transdermal therapeutic plaster |
| 12/18/1996 | CN1138318A Polyol composition produced by CO-spray-drying |
| 12/18/1996 | CN1138298A Vaccines |
| 12/18/1996 | CN1138294A Psoriasis treatment |
| 12/18/1996 | CN1137924A "Chanhouning" and its preparation method |
| 12/18/1996 | CN1137923A Traditional Chinese medicine prescription for curing chronic bronchitis |
| 12/18/1996 | CN1137920A Patent drug for curing sciatica |
| 12/18/1996 | CN1137918A Traditional Chinese medicine-"Zengxuening" for regulating organism balance |
| 12/18/1996 | CN1137917A Compound jiabing ear drops and preparation method thereof |
| 12/18/1996 | CN1137915A Jiangyatie plaster for curing hypertension |
| 12/18/1996 | CN1137914A Aconite granular preparation and its preparation method |
| 12/18/1996 | CN1137913A Brightening and spot-removing face-beautifying preparation and its preparation method |
| 12/18/1996 | CN1137909A Hemorrhoidal fistula medicine |
| 12/18/1996 | CN1137907A Preparation method of external liniment for curing pharyngitis |
| 12/18/1996 | CN1137905A Aerosol for treating burn |
| 12/18/1996 | CN1137898A Shark cartilage capsule and its preparation technology |
| 12/18/1996 | CN1137893A Improvement on "Ganpule" sugar-coated tablet form |
| 12/18/1996 | CN1137892A Preparation method of drug for curing common cold and its series product-ointment for curing common cold |
| 12/17/1996 | US5585460 Purification by dissolving in water soluble organic solvent, adding water to precipitate, recovering and washing precipitate |
| 12/17/1996 | US5585406 Nonirritating nonionic tissue cleaning method |
| 12/17/1996 | US5585386 Mixtures for application to skin or scalp |
| 12/17/1996 | US5585379 Skin disorders |
| 12/17/1996 | US5585363 Administering liposome encapsulated nucleoside analog to inhibit dna repair function of tumor cells |
| 12/17/1996 | US5585358 Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
| 12/17/1996 | US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy |
| 12/17/1996 | US5585354 Suppressant of corneal subepithelial clouding |